Usefulness of acute-phase proteins in community-acquired pneumonia;Reactantes de fase aguda en la neumonía adquirida en la comunidad

Medicina Clinica

Volumn 122, Issue 7, 2004, Pages 245-247

  Mirete, Carlos ^a,c   Gutiérrez, Félix ^a   Masiá, Mar ^a   Ramos, José Manuel ^a   Hernández, Ildefonso ^b   Soldán, Bernardo ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c NONE   (Spain)

Author keywords

Acute phase proteins; C reactive protein (CRP); Community acquired pneumonia; Erythrocyte sedimentation rate (ESR)

Indexed keywords

ACUTE PHASE PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; COMMUNICABLE DISEASE; CONFIDENCE INTERVAL; DIAGNOSTIC VALUE; EMPYEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HOSPITAL ADMISSION; HUMAN; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; PLEURA DISEASE; PLEURA EFFUSION; PNEUMONIA; PREDICTION; PROSPECTIVE STUDY; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 11144357112     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13058371     Document Type: Article

References (12)

1. Puren AJ, Feldman C, Savage N, Becker PJ, Smith C. Patterns of cytokine expression in community-acquired pneumonia. Chest 1995;107: 1342-9.
2. Antunes G, Evans SA, Lordan JL, Frew AJ. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir J 2002;20:990-5.
3. Hedlund J. Community-acquired pneumonia requiring hospitalization. Factors of importance for the short and long term prognosis. Scand J Infect Dis 1995;97:1S-60S.
4. Lieberman D, Livnat S, Schlaeffer F, Porath A, Horowitz S, Levy R. IL-1 beta and IL-6 in community-acquired pneumonia: bacteremic pneumococcal pneumonia versus Mycoplasma pneumoniae pneumonia. Infection 1997;25:90-4.
5. Castro-Guardiola A, Armengou-Arxe A, Viejo-Rodríguez A, Peñarroja-Matutano G, García-Bragado F. Differential diagnosis between community-acquired pneumonia and non-pneumonia diseases of the chest in the emergency ward. Eur J Intern Med 2000;11:334-9.
6. Martinot M, Hansmann Y, De Martino S, Lesens O, Coumaros G, Pencreach E, et al. Procalcitonin in pyelonephritis and acute community-acquired pneumonia in adults. Presse Med 2001;30:1091-6.
7. Macfarlane J, Holmes W, Gard P, Macfarlane R, Rose D, Weston V, et al. Prospective study of incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001;56:109-14.
8. Mirete Ferrer C, Gutiérrez Rodero F, Hernández Aguado I, Masiá Canuto M, Rodríguez Díaz JC, Royo García G, et al. Neumonía adquirida en la comunidad asociada a infección por el virus de la gripe. Med Clin (Barc) 2002;118:622-6.
9. Mirete Ferrer C, Gutiérrez Rodero F, Rodríguez Díaz JC, Royo García G, Shum Fhunk C, Martín Hidalgo A. Etiología de la neumonía adquirida en la comunidad tratada ambulatoriamente. Utilidad de un protocolo diagnóstico con pruebas microbiológicas convencionales y detección de ant[genos de Streptococcus pneumoniae y Legionella pneumophila en orina. Med Clin (Barc) 2001;117:657-9.
10. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk in patients with community-acquired pneumonia. N Engl J Med 1997;336: 243-50.
11. Frías J, Gomis M, Prieto J, Mensa J, Bouza E, Garcí a-Rodríguez JA, et al. Tratamiento antibiótico empírico inicial de la neumonía adquirida en la comunidad. Rev Esp Quimioter 1998;11:255-61.
12. st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, 2001.